Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Biomed Environ Sci ; 30(5): 351-362, 2017 May.
Article de Anglais | MEDLINE | ID: mdl-28549491

RÉSUMÉ

OBJECTIVE: To investigate chondrocyte apoptosis and the expression of biochemical markers associated with apoptosis in Kashin-Beck disease (KBD) and in an established T-2 toxin- and selenium (Se) deficiency-induced rat model. METHODS: Cartilages were collected from the hand phalanges of five patients with KBD and five healthy children. Sprague-Dawley rats were administered a selenium-deficient diet for 4 weeks prior to T-2 toxin exposure. The apoptotic chondrocytes were observed by terminal deoxynucleotidyl transferase dUTP nick end labeling staining. Caspase-3, p53, Bcl-2, and Bax proteins in the cartilages were visualized by immunohistochemistry, their protein levels were determined by Western blotting, and mRNA levels were determined by real-time reverse transcription polymerase chain reaction. RESULTS: Increased chondrocyte apoptosis was observed in the cartilages of children with KBD. Increased apoptotic and caspase-3-stained cells were observed in the cartilages of rats fed with normal and Se-deficient diets plus T-2 toxin exposure compared to those in rats fed with normal and Se-deficient diets. Caspase-3, p53, and Bax proteins and mRNA levels were higher, whereas Bcl-2 levels were lower in rats fed with normal or Se-deficiency diets supplemented with T-2 toxin than the corresponding levels in rats fed with normal diet. CONCLUSION: T-2 toxin under a selenium-deficient nutritional status induces chondrocyte death, which emphasizes the role of chondrocyte apoptosis in cartilage damage and progression of KBD.


Sujet(s)
Apoptose/effets des médicaments et des substances chimiques , Cartilage articulaire/physiopathologie , Chondrocytes/physiologie , Maladie de Kashin-Beck/physiopathologie , Sélénium/déficit , Toxine T-2/pharmacologie , Adolescent , Animaux , Marqueurs biologiques , Enfant , Femelle , Humains , Maladie de Kashin-Beck/étiologie , Mâle , Matrilines/génétique , Matrilines/métabolisme , Modèles animaux , Répartition aléatoire , Rats , Rat Sprague-Dawley
2.
Adv Nutr ; 7(2): 279-86, 2016 Mar.
Article de Anglais | MEDLINE | ID: mdl-26980811

RÉSUMÉ

Many studies have reported that olive oil-based lipid emulsion (LE) formulas of soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) may be a viable alternative for parenteral nutrition. However, some randomized controlled clinical trials (RCTs) have raised concerns regarding the nutritional benefits and safety of SMOFs. We searched principally the MEDLINE, Cumulative Index to Nursing and Allied Health Literature, Scopus, EMBASE, and Cochrane Central Register of Controlled Trials databases from inception to March 2014 for the relevant literature and conducted a meta-analysis of 15 selected RCTs that 1) compared either olive oil- or SMOF-based LEs with soybean oil-based LEs and 2) reported plasma concentrations of α-tocopherol, oleic acid, and ω-6 (n-6) and ω-3 (n-3) long-chain polyunsaturated fatty acids (PUFAs) and liver concentrations of total bilirubin and the enzymes alanine transaminase, aspartate transaminase, alkaline phosphatase, and γ-glutamyl transferase. The meta-analysis suggested that SMOF-based LEs were associated with higher plasma concentrations of plasma α-tocopherol, oleic acid, and the ω-3 PUFAs eicosapentaenoic and docosahexaenoic acid. Olive oil- and SMOF-based LEs correlated with lower plasma concentrations of long-chain ω-6 PUFAs and were similar to soybean oil-based LEs with regard to their effects on liver function indicators. In summary, olive oil- and SMOF-based LEs have nutritional advantages over soybean oil-based LEs and are similarly safe. However, their performance in clinical settings requires further investigation.


Sujet(s)
Maladies de carence/prévention et contrôle , Médecine factuelle , Émulsion lipidique intraveineuse/usage thérapeutique , Acides gras indispensables/usage thérapeutique , Huile d'olive/usage thérapeutique , Nutrition parentérale/méthodes , Huile de soja/usage thérapeutique , Maladies de carence/sang , Émulsion lipidique intraveineuse/effets indésirables , Acides gras indispensables/effets indésirables , Acides gras indispensables/sang , Acides gras indispensables/déficit , Huiles de poisson/effets indésirables , Huiles de poisson/usage thérapeutique , Humains , Huile d'olive/effets indésirables , Nutrition parentérale/effets indésirables , Essais contrôlés randomisés comme sujet , Huile de soja/effets indésirables
3.
Brain Res ; 1574: 37-49, 2014 Jul 29.
Article de Anglais | MEDLINE | ID: mdl-24924805

RÉSUMÉ

Previous research has demonstrated that diabetes induces learning and memory deficits. However, the mechanism of memory impairment induced by diabetes is poorly understood. Dietary fatty acids, especially polyunsaturated fatty acids, have been shown to enhance learning and memory and prevent memory deficits in various experimental conditions. The present study investigated the effects of fish oil supplementation on the neuron apoptosis in the hippocampus of streptozotocin (STZ)-induced diabetes rats, further explored the effect of fish oil on the phosphorylation of protein kinase B and glycogen synthase kinase-3 beta. The effects of diabetes and fish oil treatment on the spatial learning and memory were also evaluated using the Morris Water Maze. STZ-induced diabetes impaired spatial learning and memory of rats, which was associated with the apoptosis of hippocampal neurons and oxidative stress. Fish oil administration ameliorated cognitive deficit, reduced oxidative stress, increased AKT phosphorylation, decreased GSK-3ß phosphorylation, and decreased pro-apoptotic molecules expression, which protected the hippocampal neurons from apoptosis in diabetic rats. These results suggested a potential role for fish oil as an adjuvant therapy for the prevention and treatment of diabetic complications.


Sujet(s)
Apoptose/physiologie , Diabète expérimental/diétothérapie , Huiles de poisson/administration et posologie , Glycogen Synthase Kinase 3/métabolisme , Hippocampe/enzymologie , Neurones/enzymologie , Animaux , Glycémie/métabolisme , Diabète expérimental/enzymologie , Diabète expérimental/anatomopathologie , Compléments alimentaires , Glycogen synthase kinase 3 beta , Hippocampe/anatomopathologie , Mâle , Apprentissage du labyrinthe , Neurones/anatomopathologie , Stress oxydatif/physiologie , Phosphorylation , Protéines proto-oncogènes c-akt/métabolisme , Répartition aléatoire , Rat Sprague-Dawley , Transduction du signal , Mémoire spatiale/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE